These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2993733)

  • 1. The effect of wheat bran on the pharmacokinetics of phenprocoumon in normal volunteers.
    Kitteringham NR; Mineshita S; Ohnhaus EE
    Klin Wochenschr; 1985 Jun; 63(12):537-9. PubMed ID: 2993733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of liver cirrhosis on the pharmacokinetics of phenprocoumon.
    Kitteringham NR; Büstgens L; Brundert E; Mineshita S; Ohnhaus EE
    Eur J Clin Pharmacol; 1984; 26(1):65-70. PubMed ID: 6714293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between phenprocoumon and phytomenadion: a pharmacokinetic investigation in healthy volunteers.
    Haustein KO
    Biomed Biochim Acta; 1984; 43(12):1417-24. PubMed ID: 6534380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separation of the enantiomers of phenprocoumon and warfarin by high-performance liquid chromatography using a chiral stationary phase. Determination of the enantiomeric ratio of phenprocoumon in human plasma and urine.
    de Vries JX; Völker U
    J Chromatogr; 1989 Aug; 493(1):149-56. PubMed ID: 2778004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic fate of phenprocoumon in humans.
    Toon S; Heimark LD; Trager WF; O'Reilly RA
    J Pharm Sci; 1985 Oct; 74(10):1037-40. PubMed ID: 4078699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of dimethylbiguanide on phenprocoumon elimination and its mode of action. A drug interaction study.
    Ohnhaus EE; Berger W; Duckert F; Oesch F
    Klin Wochenschr; 1983 Sep; 61(17):851-8. PubMed ID: 6632727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral contraceptive steroids on the pharmacokinetics of phenprocoumon.
    Mönig H; Baese C; Heidemann HT; Ohnhaus EE; Schulte HM
    Br J Clin Pharmacol; 1990 Jul; 30(1):115-8. PubMed ID: 2390422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of sulfinpyrazone on the disposition of pseudoracemic phenprocoumon in humans.
    Heimark LD; Toon S; Gibaldi M; Trager WF; O'Reilly RA; Goulart DA
    Clin Pharmacol Ther; 1987 Sep; 42(3):312-9. PubMed ID: 3621786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interruption of the enterohepatic circulation of phenprocoumon by cholestyramine.
    Meinertz T; Gilfrich HJ; Groth U; Jonen HG; Jähnchen E
    Clin Pharmacol Ther; 1977 Jun; 21(6):731-5. PubMed ID: 862312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Observations in phenprocoumon (Marcumar) poisoning. Elimination and serum binding of the anticoagulant atatoxic blood concentration].
    Held H; von Busse G; Meissner J
    Dtsch Med Wochenschr; 1980 Jun; 105(24):860-3. PubMed ID: 7418621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cholestyramine interrupts the enterohepatic circulation of phenprocoumon: a new therapeutic possibility in the treatment of phenprocoumon overdose].
    Meinertz T; Jähnchen E; Gilfrich HJ; Groth U; Jonen HG
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1582-4. PubMed ID: 347787
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of guar an phenprocoumon concentration in serum and on coagulation reaction parameters of orally administered phenprocoumon].
    Kasper H; Barthel S; Feldmann K; Trobisch H; Schrezenmeir J
    Beitr Infusionther Klin Ernahr; 1983; 12():56-60. PubMed ID: 6316918
    [No Abstract]   [Full Text] [Related]  

  • 13. Investigations into the binding of phenprocoumon to albumin using fluorescence spectroscopy.
    Otagiri M; Fleitman JS; Perrin JH
    J Pharm Pharmacol; 1980 Jul; 32(7):478-82. PubMed ID: 6105183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of induction and inhibition of drug metabolism on pharmacokinetics and anticoagulant activity of the enantiomers of phenprocoumon in rats.
    Schmidt W; Trenk D; Jähnchen E
    Pharmacology; 1980; 21(5):313-22. PubMed ID: 7433511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study on interactions between pirprofen and phenprocoumon].
    Marbet GA; Duckert F; Schönenberger PM
    Fortschr Med; 1985 Feb; 103(SPEC NO 7A):207-9. PubMed ID: 3872834
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic interactions between phenprocoumon and atenolol or metoprolol.
    Spahn H; Kirch W; Mutschler E; Ohnhaus EE; Kitteringham NR; Lögering HJ; Paar D
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):97S-102S. PubMed ID: 6743480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective drug distribution and anticoagulant potency of the enantiomers of phenprocoumon in rats.
    Schmidt W; Jähnchen E
    J Pharm Pharmacol; 1977 May; 29(5):266-71. PubMed ID: 17688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics and clinical importance of the interactions of rifampicin with phenprocoumone and isoniazide].
    von Oldershausen HF; Musch E; Rudolf G; Gieraths A; Schunter C
    Verh Dtsch Ges Inn Med; 1978; (84):1468-72. PubMed ID: 741993
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study on possible interactions between tiaprofenic acid and phenprocoumon (author's transl)].
    Dürr J; Pfeiffer MH; Penth B; Wetzelsberger K; Lücker PW
    Arzneimittelforschung; 1981; 31(12):2163-7. PubMed ID: 7199320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the anticoagulant phenprocoumon in human plasma and urine by high-performance liquid chromatography.
    De Vries JX; Harenberg J; Walter E; Zimmermann R; Simon M
    J Chromatogr; 1982 Aug; 231(1):83-92. PubMed ID: 7119068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.